Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 16761935)

  • 1. Targeting cellular FLICE-like inhibitory protein as a novel approach to the treatment of Hodgkin's lymphoma.
    Dutton A; Burns AT; Young LS; Murray PG
    Expert Rev Anticancer Ther; 2006 Jun; 6(6):911-9. PubMed ID: 16761935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated death.
    Dutton A; O'Neil JD; Milner AE; Reynolds GM; Starczynski J; Crocker J; Young LS; Murray PG
    Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6611-6. PubMed ID: 15096587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells.
    Guo F; Sun A; Wang W; He J; Hou J; Zhou P; Chen Z
    Mol Immunol; 2009 Aug; 46(13):2441-8. PubMed ID: 19540595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCAAT/enhancer binding protein homologous protein-dependent death receptor 5 induction and ubiquitin/proteasome-mediated cellular FLICE-inhibitory protein down-regulation contribute to enhancement of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by dimethyl-celecoxib in human non small-cell lung cancer cells.
    Chen S; Liu X; Yue P; Schönthal AH; Khuri FR; Sun SY
    Mol Pharmacol; 2007 Nov; 72(5):1269-79. PubMed ID: 17684158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of cellular FLICE inhibitory protein (c-FLIP) in the pathogenesis and treatment of cancer.
    Dutton A; Young LS; Murray PG
    Expert Opin Ther Targets; 2006 Feb; 10(1):27-35. PubMed ID: 16441226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies.
    Zhao X; Qiu W; Kung J; Zhao X; Peng X; Yegappan M; Yen-Lieberman B; Hsi ED
    Leuk Res; 2008 Feb; 32(2):275-85. PubMed ID: 17659339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cFLIP regulation of lymphocyte activation and development.
    Budd RC; Yeh WC; Tschopp J
    Nat Rev Immunol; 2006 Mar; 6(3):196-204. PubMed ID: 16498450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells.
    Thomas RK; Kallenborn A; Wickenhauser C; Schultze JL; Draube A; Vockerodt M; Re D; Diehl V; Wolf J
    Am J Pathol; 2002 Apr; 160(4):1521-8. PubMed ID: 11943736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cell death ligand and receptor system on regulation of follicular atresia in pig ovaries.
    Manabe N; Matsuda-Minehata F; Goto Y; Maeda A; Cheng Y; Nakagawa S; Inoue N; Wongpanit K; Jin H; Gonda H; Li J
    Reprod Domest Anim; 2008 Jul; 43 Suppl 2():268-72. PubMed ID: 18638134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.
    Kim YH; Jung EM; Lee TJ; Kim SH; Choi YH; Park JW; Park JW; Choi KS; Kwon TK
    Free Radic Biol Med; 2008 Mar; 44(6):1055-68. PubMed ID: 18164688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid up-regulation of c-FLIP expression by BCR signaling through the PI3K/Akt pathway inhibits simultaneously induced Fas-mediated apoptosis in murine B lymphocytes.
    Moriyama H; Yonehara S
    Immunol Lett; 2007 Mar; 109(1):36-46. PubMed ID: 17275920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FLICE-like inhibitory protein blocks transforming growth factor beta 1-induced caspase activation and apoptosis in prostate epithelial cells.
    Nastiuk KL; Yoo K; Lo K; Su K; Yeung P; Kutaka J; Danielpour D; Krolewski JJ
    Mol Cancer Res; 2008 Feb; 6(2):231-42. PubMed ID: 18314484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical aspects and primary therapy of Hodgkin's lymphomas].
    Sieber M; Tesch H; Diehl V
    Praxis (Bern 1994); 1996 Mar; 85(12):364-70. PubMed ID: 8643899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicity.
    Böll B; Eltaib F; Reiners KS; von Tresckow B; Tawadros S; Simhadri VR; Burrows FJ; Lundgren K; Hansen HP; Engert A; von Strandmann EP
    Clin Cancer Res; 2009 Aug; 15(16):5108-16. PubMed ID: 19671844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathogenesis of Hodgkin's lymphoma.
    Re D; Küppers R; Diehl V
    J Clin Oncol; 2005 Sep; 23(26):6379-86. PubMed ID: 16155023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fas signaling in thyroid carcinomas is diverted from apoptosis to proliferation.
    Mitsiades CS; Poulaki V; Fanourakis G; Sozopoulos E; McMillin D; Wen Z; Voutsinas G; Tseleni-Balafouta S; Mitsiades N
    Clin Cancer Res; 2006 Jun; 12(12):3705-12. PubMed ID: 16778096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mRNA expression patterns indicate CD30 mediated activation of different apoptosis pathways in anaplastic large cell lymphoma but not in Hodgkin's lymphoma.
    Staber PB; Noehammer C; Dürkop H; Schauer S; Kenner L; Linkesch W; Hoefler G
    Leuk Res; 2006 Mar; 30(3):343-8. PubMed ID: 16198418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant FHIT protein expression in classical Hodgkin's lymphoma: a potential marker.
    Zhao P; Lam AK; Lu YL; Zhong M; Chen LH; Pu XL
    Pathology; 2006 Oct; 38(5):399-402. PubMed ID: 17008276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The story about Hodgkin's lymphoma].
    Ostojić Kolonić S
    Acta Med Croatica; 2008 Oct; 62(4):409-12. PubMed ID: 19205418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of CD30 in anaplastic large cell lymphoma is regulated by nucleophosmin-anaplastic lymphoma kinase-mediated JunB level in a cell type-specific manner.
    Hsu FY; Johnston PB; Burke KA; Zhao Y
    Cancer Res; 2006 Sep; 66(18):9002-8. PubMed ID: 16982741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.